• A critical juncture

    Leslie Galloway looks back over 2020, outlining the challenges faced by the life sciences sector and the potential opportunities that lie ahead

  • Responding to the crisis

    Oli Hudson explores the changes that have occurred in the NHS this year as the Long Term Plan has been rolled out at speed in response to the COVID crisis

  • Movers and shakers

    As mega deals slow, private capital becomes the driving force behind 2020 M&A

News

View all

Web Exclusives

View all
Thumbnail image for A threat to innovation?

A threat to innovation?

Could recent legal decisions on Supplementary Protection Certificates (SPCs) prove to be a hammer blow for the pharma industry?

Thumbnail image for Progress in personalised renal dosing

Progress in personalised renal dosing

Dose adjustment based on a patient's renal function is a very current example of personalising therapy. While this kind of precision medicine holds great potential, it is often overlooked, particularly in younger patients. Darcie Streetman and Rachel Eyler explore the growing knowledge and tools available for optimising renal dosing.

Thumbnail image for SMART PEOPLE INSIGHT: Dr Jan Westerink

SMART PEOPLE INSIGHT: Dr Jan Westerink

A new, pooled analysis of data from Novo Nordisk’s Phase III trials SUSTAIN 6 and PIONEER 6 shows that semaglutide may help patients with type 2 diabetes live longer without a cardiovascular event. PharmaTimes talks to lead study investigator Dr Jan Westerink about the importance of these findings

Thumbnail image for R&D trends

R&D trends

Accelerating innovation and its impact on patients and sites

Thumbnail image for Movers and shakers

Movers and shakers

As mega deals slow, private capital becomes the driving force behind 2020 M&A

Thumbnail image for Responding to the crisis

Responding to the crisis

Oli Hudson explores the changes that have occurred in the NHS this year as the Long Term Plan has been rolled out at speed in response to the COVID crisis

Thumbnail image for A critical juncture

A critical juncture

Leslie Galloway looks back over 2020, outlining the challenges faced by the life sciences sector and the potential opportunities that lie ahead

Thought Leadership

View all

Webinars

View all

Designing Pharma organisations for success

Across all industries, people are changing the ways they engage with products, services, and brands. View more...

Wednesday, 28 September 2016 - 11:00 am
George Underwood
FREE - Listen again now - | VIEW NOW

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download